Citations 1
ILLUMINATE-B, a Phase 3 Open-Label Study to Evaluate Lumasiran, an RNAi Therapeutic, in Young Children with Primary Hyperoxaluria Type 1 (PH1)
Michael, Mini , Cochat, Pierre , Magen, Daniella , Hoff, William van’t , Sas, David J. , Schalk, Gesa, Shasha‐Lavsky, Hadas , Bae, Kyounghwa, Seddighzadeh, Ali, Garg, Pushkal, Vaishnaw, Akshay, McGregor, Tracy L., Fujita, Kenji P. , Frishberg, Yaacov, Deschênes, Georges , Hayes, Wesley Nathan
Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 515-515
